Table 3 IQGAP3, B7-H4, COX-2, CEA and CA19-9 levels in different patient groups

Cases (n)

85

118

22

32

34

30

IQGAP3

Levels (mean ± SD, pg/ml)

191.97 ± 103.96

312.68 ± 101.91

180.33 ± 71.10

185.57 ± 84.10

272.78 ± 79.20

382.71 ± 76.76

P

< 0.001^#

= 0.284*

= 0.412**

< 0.001***

< 0.001^##

CV

54.2

32.6

39.4

45.3

29.0

20.1

B7-H4

Levels (mean ± SD, ng/ml)

64.78 ± 16.73

97.85 ± 15.56

81.23 ± 9.32

89.44 ± 10.53

96.56 ± 17.53

103.30 ± 11.88

P

< 0.001^#

= 0.003*

= 0.001**

< 0.001***

< 0.001^##

CV

25.8

15.9

11.5

11.8

18.2

11.5

COX-2

Levels (mean ± SD, ng/ml)

25.78 ± 16.09

48.55 ± 13.43

37.12 ± 11.02

45.33 ± 9.89

51.02 ± 10.17

53.44 ± 8.76

P

< 0.001^#

= 0.001*

< 0.001**

< 0.001***

< 0.001^##

CV

62.4

27.7

29.7

21.8

19.9

16.4

CEA

Levels (mean ± SD, ng/ml)

3.41 ± 1.27

6.22 ± 4.49

5.34 ± 1.17

5.92 ± 1.85

6.08 ± 3.82

6.34 ± 2.14

P

< 0.001^#

= 0.004*

= 0.001**

< 0.001***

< 0.001^##

CV

37.2

72.2

21.9

31.3

62.8

33.8

CA19-9

Levels (mean ± SD, U/ml)

19.24 ± 10.08

29.92 ± 8.97

27.19 ± 8.87

29.81 ± 9.43

30.90 ± 10.16

31.5 ± 9.58

P

< 0.001^#

< 0.001*

< 0.001**

< 0.001***

< 0.001^##

CV

52.4

30.0

32.6

31.6

32.9

30.4